The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
Paolo Prandoni(University of Padua), Antonio Pagnan, M. Iotti(University of Padua), Daniela Tormene, Paolo Simioni(University of Padua), Raffaele Pesavento(University of Padua), Enrico Bernardi(Amsterdam UMC Location University of Amsterdam), Franco Noventa(University of Padua), Angelo Ghirarduzzi(University of Padua), Vittorio Pengo(University of Padua)
Cited by 774
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure
|Thrombosis and Haemostasis|2020|738
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
|New England Journal of Medicine|1992|685